Terminated PHASE1 INTERVENTIONAL 2-arm NCT02562820

An Exploratory Trial of Ketamine for the Treatment of Rett Syndrome

Ketamine for the Treatment of Rett Syndrome: An Exploratory Trial

Sponsor: The Cleveland Clinic

Updated 7 times since 2017 Last updated: Aug 28, 2017 Started: Nov 30, 2015 Primary completion: Jul 31, 2017 Completion: Jul 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Funding withdrawn

Other terminated trials from The Cleveland Clinic

See all terminations from The Cleveland Clinic

A PHASE1 clinical study on Rett Syndrome, this trial is terminated or withdrawn. The trial is conducted by The Cleveland Clinic and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1
Sep 2017 — Jun 2018 [monthly]

Terminated PHASE1

Status: Active Not Recruiting → Terminated

▶ Show 2 earlier versions

Feb 2017 — Sep 2017 [monthly]

Active Not Recruiting PHASE1
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE1

First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Cleveland Clinic

Data source: The Cleveland Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cleveland, United States